Pharma Innovation INDUSTRY SPENDS IN R&D USD 141.6 billion per year Drugs in development for particular diseases 1,813 Cancer 475 Diabetes 159 HIV/AIDS 599 Cardiovascular ANNUAL SPENDING BY THE PHARMACEUTICAL INDUSTRY IS 5 times greater than the defense & aerospace industries 5 OF THE 10 LEADING GLOBAL R&D firms were Research-based Pharmaceultical Companies
Pharma & Global Health BETWEEN 2000-2008 VACCINES HELPED REDUCE NUMBER OF MEASLES DEATHS IN AFRICA BY 92% 186 ongoingR&D Projects In 2014 IFPMA members had 186 ongoing R&D projects regarding diseases of the developing world We are the 3rd largest global funder in NTDs research 88% 164 projects for NTDs are in partnership between IFPMA member companies and +80 partners from universities, public and private sector, and NGOs. OUR INVESTMENTS IN NTDs RESEARCH REACHED USD 401.2 million in 2013 8 R&D centers are solely dedicated to searching for new cures for NTDs 500 million immunized Since 2000
Pharma Economic Footprint PHARMACEUTICAL MARKET WILL REACH USD 1.3 trillion BY 2018 Global health partnerships IFPMA members have a strong track record in building strategic alliances for global health IN 2012, pharmaceutical industry gross value added was USD 436.8 billion To the World GDP similar to the economy of a country like Argentina The global pharmaceutical industry employs over 4.44 million people AND PAID USD 91.3 billion IN SALARIES IN 2013 (Including Generics)
